Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Harrow Health (HROW – Research Report) and Surgery Partners (SGRY – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Harrow Health (HROW)
In a report released yesterday, Steven Seedhouse from Cantor Fitzgerald maintained a Buy rating on Harrow Health, with a price target of $94.00. The company’s shares closed last Monday at $53.59, close to its 52-week high of $59.23.
According to TipRanks.com, Seedhouse is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Harrow Health with a $74.00 average price target, implying a 38.3% upside from current levels. In a report released today, TipRanks – Google also upgraded the stock to Buy with a $59.00 price target.
See today’s best-performing stocks on TipRanks >>
Surgery Partners (SGRY)
In a report released yesterday, Sarah James from Cantor Fitzgerald maintained a Buy rating on Surgery Partners, with a price target of $33.00. The company’s shares closed last Monday at $15.88.
According to TipRanks.com, James is a 4-star analyst with an average return of
Currently, the analyst consensus on Surgery Partners is a Strong Buy with an average price target of $24.25.
